Advertisement
  • A New Type of Drug Approval

    At the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.

    by Kate Yandell

  • Non–Small Cell Lung Cancer Takes Center Stage

    A trio of clinical trials at the AACR Annual Meeting spotlight new avenues for non-small cell lung cancer treatment.

    by Brad Jones

  • Pembrolizumab Shows Further Promise for Melanoma

    In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected.

    by Brad Jones

  • A Better Way to Screen for Lynch Syndrome?

    Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.

    by Cheryl Platzman Weinstock

  • Forward Look

    Banking on Bacteria

    Response to immunotherapy may be linked to gut microbiome.

    by Chris Palmer

  • Forward Look

    Improving Cancer Care in Sub-Saharan Africa

    New guidelines account for limited medical resources.

    by Cameron Walker

  • Forward Look

    Treating Early-Stage Lung Cancer

    Efforts are underway to define role of high-dose radiation.

    by Stephen Ornes

  • Healthy Habits

    Head Start

    Developing healthy behaviors in young adulthood can help reduce cancer risk later in life.

    by Brenda Conaway

  • Searching Blood for Cancer Clues

    Researchers are developing blood tests that help track and identify molecular changes in tumors. But many hurdles remain before these “liquid biopsies” become standard.

    by Stephen Ornes

  • Liver Cancer on the Rise

    Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.

    by Sue Rochman